Cytomegalovirus disease in African-American kidney transplant patients-Reference-Cited by-同舟云学术

Cytomegalovirus disease in African-American kidney transplant patients

Published:2012-12 Issue:6 Volume:14 Page:604-610
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

McGee J.¹,Mave V.²,Yau C.L.³,Killackey M.¹,Paramesh A.¹,Buell J.¹,Slakey D.P.¹,Hamm L.L.²,Zhang R.²

Affiliation:

1. Department of Surgery; Tulane University School of Medicine; New Orleans; Louisiana; USA

2. Department of Medicine; Tulane University School of Medicine; New Orleans; Louisiana; USA

3. Department of Biostatistics; Tulane University School of Public Health and Tropical Medicine; New Orleans; Louisiana; USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-3062.2012.00759.x/fullpdf

Reference31 articles.

1. Cytomegalovirus in renal transplantation;Brennan;J Am Soc Nephrol,2001

2. Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group;San Juan;Am J Transplant,2007

3. International consensus guidelines on the management of cytomegalovirus infection in solid organ transplantation;Kotton;Transplantation,2010

4. Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial;Kleim;Am J Transplant,2008

5. Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation;Reischig;Am J Transplant,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for cytomegalovirus infection and disease after kidney transplantation: A meta-analysis;Transplant Immunology;2022-10

2. Epidemiology, risk factors, and outcomes associated with cytomegalovirus in adult kidney transplant recipients: A systematic literature review of real‐world evidence;Transplant Infectious Disease;2020-10-22

3. Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study;Transplant Infectious Disease;2017-05-09

4. CMV Viremia Is Associated With a Decreased Incidence of BKV Reactivation after Kidney and Kidney-Pancreas Transplantation;Transplantation;2013-12-27

5. Prophylaxis of human cytomegalovirus infection in renal transplant patients with valacyclovir and ganciclovir;ACTA VIROL;2013